After testing BRAF status in primary melanoma and lymph node samples, they demonstrated that BRAF mutation was associated with a 4.5-fold higher risk of death compared to the wild-type group, suggesting a notable role of the kinase in tumor spread. Here, BRAF is linked to melanoma.